# QIAstat-Dx® BCID Plus AMR Panels Clinical Performance Study

> **NCT05305534** · — · COMPLETED · sponsor: **QIAGEN Gaithersburg, Inc** · enrollment: 2142 (actual)

## Conditions studied

- Blood Disease

## Interventions

- **DEVICE:** QIAstat-Dx® BCID GN and GPF Plus AMR Panels

## Key facts

- **NCT ID:** NCT05305534
- **Lead sponsor:** QIAGEN Gaithersburg, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-01
- **Primary completion:** 2025-04-10
- **Final completion:** 2025-08-25
- **Target enrollment:** 2142 (ACTUAL)
- **Last updated:** 2025-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05305534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05305534, "QIAstat-Dx® BCID Plus AMR Panels Clinical Performance Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05305534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*